Yamamoto, Akira
Kyoto Pharmaceutical University,
Japan
2025 Rank: 249342
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1987 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 249342 | 263562 |
| Total Cites | 476 | 548 |
| H-index | 10 | 10 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 13 | 13 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 50 | 50 |
| Total Cites to Single+First Authored Papers | 36 | 44 |
| Number of Single+First+Last Authored Papers | 194 | 194 |
| Total Cites to Single+First+Last Authored Papers | 362 | 410 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 388 | 402 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.36 |
| Self-Citation Percentage |
13.14%
|
|
Yamamoto, Akira
Kyoto Pharmaceutical University,
Japan
2024 Rank: 275828
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2230 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 275828 | 315187 |
| Total Cites | 458 | 475 |
| H-index | 9 | 9 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 25 | 25 |
| Number of Single+First+Last Authored Papers | 184 | 184 |
| Total Cites to Single+First+Last Authored Papers | 330 | 342 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 368 | 377 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.26 |
| Self-Citation Percentage |
3.58%
|
|
Yamamoto, Akira
Kyoto Pharmaceutical University,
Japan
2023 Rank: 201397
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1548 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 201397 | 215143 |
| Total Cites | 481 | 515 |
| H-index | 9 | 10 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 26 | 26 |
| Number of Single+First+Last Authored Papers | 184 | 184 |
| Total Cites to Single+First+Last Authored Papers | 346 | 368 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 402 | 417 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.24 |
| Self-Citation Percentage |
6.60%
|
|
Yamamoto, Akira
Kyoto Pharmaceutical University,
Japan
2022 Rank: 187563
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1449 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 187563 | 212225 |
| Total Cites | 462 | 503 |
| H-index | 8 | 8 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 33 | 33 |
| Number of Single+First+Last Authored Papers | 181 | 181 |
| Total Cites to Single+First+Last Authored Papers | 332 | 356 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 354 | 373 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.35 |
| Self-Citation Percentage |
8.15%
|
|
Yamamoto, Akira
Kyoto Pharmaceutical University,
Japan
2021 Rank: 254978
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 2049 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 254978 | 209434 |
| Total Cites | 636 | 782 |
| H-index | 9 | 11 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 35 | 53 |
| Number of Single+First+Last Authored Papers | 176 | 176 |
| Total Cites to Single+First+Last Authored Papers | 468 | 567 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 504 | 540 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.45 |
| Self-Citation Percentage |
18.67%
|
|
Yamamoto, Akira
Kyoto Pharmaceutical University,
Japan
2020 Rank: 275874
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 2063 out of 94611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 275874 | 242480 |
| Total Cites | 469 | 585 |
| H-index | 9 | 9 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 48 | 48 |
| Total Cites to Single+First Authored Papers | 26 | 45 |
| Number of Single+First+Last Authored Papers | 169 | 169 |
| Total Cites to Single+First+Last Authored Papers | 331 | 414 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 363 | 389 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.50 |
| Self-Citation Percentage |
19.83%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.